PSYCH OpenIR  > 中国科学院心理健康重点实验室
Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor
Bian, Li-hua1; Yao, Zi-wei1; Zhao, Cheng-bowen1; Li, Qiu-yu1; Shi, Jin-li1; Guo, Jian-you2
通讯作者邮箱shijl@vip.sina.com (jin-li shi) ; bioyou@126.com (jian-you guo)
心理所单位排序2
摘要

Nardostachyos Radix et Rhizoma (nardostachys) is the root and rhizome of Nardostachys jatamansi DC. Recent studies have shown that nardostachys may exert an anti-PD effect. In this study, the UHPLC-LTQ-Orbitrap-MS method was used to analyze the brain components of nardostachys in rats. Based on the results of UHPLC-LTQ-Orbitrap-MS analysis, nardosinone was identified to be the most effective anti-PD compound in nardostachys. To further verify this inference, a mouse PD model was established and the effect of nardosinone on PD mice was determined using classic behavioral tests. The results showed that nardosinone was indeed effective for relieving PD symptoms in mice. Moreover, network pharmacology analysis was used to elucidate the mechanism underlying the anti-PD effect of nardosinone. Dopamine receptor D2 (DRD2) was identified as the key target of nardosinone-PD interaction network, which was further verified by molecular docking and Western blotting. The results demonstrated that nardosinone and DRD2 could interact with each other. Furthermore, the expression level of DRD2 was decreased in the brain tissue of PD mice, and nardosinone could restore its expression to a certain extent. In conclusion, our findings suggest that nardosinone may reduce the motor and cognitive symptoms in the animal PD model by regulating DRD2 expression.

2021-08-14
语种英语
DOI10.1155/2021/6686965
发表期刊EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
ISSN1741-427X
卷号2021页码:14
期刊论文类型实证研究
URL查看原文
收录类别SCI
资助项目National Natural Science Foundation of China[81673560]
出版者HINDAWI LTD
WOS关键词NARDOSTACHYS-JATAMANSI ; NETWORK PHARMACOLOGY ; POLYMORPHISMS ; EXPOSURE ; DRD2 ; ASSOCIATION
WOS研究方向Integrative & Complementary Medicine
WOS类目Integrative & Complementary Medicine
WOS记录号WOS:000687476200001
WOS分区Q2
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://ir.psych.ac.cn/handle/311026/48222
专题中国科学院心理健康重点实验室
作者单位1.Beijing Univ Chinese Med, Sch Chinese Mat Med, 11A North Third Ring East Rd, Beijing 100029, Peoples R China;
2.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, 4A Datun Rd, Beijing 100101, Peoples R China
推荐引用方式
GB/T 7714
Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,et al. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,2021:14.
APA Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,Li, Qiu-yu,Shi, Jin-li,&Guo, Jian-you.(2021).Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,14.
MLA Bian, Li-hua,et al."Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor".EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2021(2021):14.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
百度学术
百度学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
必应学术
必应学术中相似的文章
[Bian, Li-hua]的文章
[Yao, Zi-wei]的文章
[Zhao, Cheng-bowen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。